Literature DB >> 12888590

Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact.

Fausto Baldanti1, Giuseppe Gerna.   

Abstract

The incidence of human cytomegalovirus (HCMV) disease in AIDS patients decreased dramatically after the introduction, a few years ago, of highly active antiretroviral combination therapy. As a consequence, the emergence of drug-resistant HCMV strains is no longer a major problem in HIV-infected individuals. However, HCMV resistance to antiviral drugs is presently recognized as an emerging problem in transplantation settings. The mechanisms of HCMV drug resistance will be analysed along with the clinical features relevant to the emergence of drug-resistant HCMV strains during antiviral treatment of patients receiving either solid organ or haematopoietic stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12888590     DOI: 10.1093/jac/dkg354

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  Natural polymorphism of cytomegalovirus DNA polymerase lies in two nonconserved regions located between domains delta-C and II and between domains III and I.

Authors:  Anne-Marie Fillet; Laetitia Auray; Sophie Alain; Karine Gourlain; Berthe Marie Imbert; Fatiha Najioullah; Gael Champier; Stéphanie Gouarin; Jocelyne Carquin; Nadhira Houhou; Isabelle Garrigue; Alexandra Ducancelle; Danielle Thouvenot; Marie-Christine Mazeron
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

2.  Novel real-time monitoring system for human cytomegalovirus-infected cells in vitro that uses a green fluorescent protein-PML-expressing cell line.

Authors:  T Ueno; Y Eizuru; H Katano; T Kurata; T Sata; S Irie; K Ogawa-Goto
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

3.  Use of time-saving flow cytometry for rapid determination of resistance of human cytomegalovirus to ganciclovir.

Authors:  Gyu-Cheol Lee; Dong-Gun Lee; Su-Mi Choi; Jin-Hong Yoo; Sun-Hee Park; Jung-Hyun Choi; Woo-Sung Min; Ok-Hee Cho; Chan-Hee Lee; Wan-Shik Shin
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Phosphonoformic acid inhibits viral replication by trapping the closed form of the DNA polymerase.

Authors:  Karl E Zahn; Egor P Tchesnokov; Matthias Götte; Sylvie Doublié
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

5.  Suppressive effects of sirtinol on human cytomegalovirus (hCMV) infection and hCMV-induced activation of molecular mechanisms of senescence and production of reactive oxygen species.

Authors:  Genxiang Mao; Huifen Li; Xiang Ding; Xin Meng; Guofu Wang; Sean X Leng
Journal:  Mech Ageing Dev       Date:  2016-01-04       Impact factor: 5.432

6.  Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome.

Authors:  Douglas A Jabs; Barbara K Martin; Michelle O Ricks; Michael S Forman
Journal:  J Infect Dis       Date:  2006-05-10       Impact factor: 5.226

7.  Functional characterization of novel mutations in UL54 of ganciclovir resistant HCMV strain using structural analysis.

Authors:  Jambulingam Malathi; Vetrivel Umashankar; Ravichandran Sathyabaarathi; Sivashanmugan Muthukumaran; Murali Ishwarya; Hajib Narahari Madhavan
Journal:  Bioinformation       Date:  2011-02-07

Review 8.  Emerging rapid resistance testing methods for clinical microbiology laboratories and their potential impact on patient management.

Authors:  Hagen Frickmann; Wycliffe Omurwa Masanta; Andreas E Zautner
Journal:  Biomed Res Int       Date:  2014-09-17       Impact factor: 3.411

9.  Assessment of the Human Cytomegalovirus UL97 Gene for Identification of Resistance to Ganciclovir in Iranian Immunosuppressed Patients.

Authors:  Hossein Keyvani; Sedigheh Taghinezhad Saroukalaei; Amir Hossein Mohseni
Journal:  Jundishapur J Microbiol       Date:  2016-05-29       Impact factor: 0.747

Review 10.  [Viral pneumonia in immunocompetent patients].

Authors:  B Guery; T d'Escrivan; H Georges; L Legout; O Leroy; N Viget; K Faure
Journal:  Reanimation       Date:  2004-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.